# Efficacy and Safety of Eleveld PK/PD Model-based Dosing During General Anesthesia

> **NCT07675850** · PHASE4 · RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 68 (estimated)

## Conditions studied

- Remimazolam
- Pharmacokinetics and Pharmacodynamics

## Interventions

- **DRUG:** Eleveld model-guided dosing
- **DRUG:** Standard weight-based label dosing

## Key facts

- **NCT ID:** NCT07675850
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-05
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-05-31
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2026-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675850, "Efficacy and Safety of Eleveld PK/PD Model-based Dosing During General Anesthesia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*